Steven M. Bachert is CRO at Enfusion, Inc. (ENFN). They have made 1 open-market trade across 1 company since 2022, most recently 2023-01-25.
CIK 0001880083
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENFN | 199,964 | $2.2M |
Shares reported on the most recent Form 4, priced at the 2023-01-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENFN | SELL | 2022-11-14 | 2022-11-16 | $13.69 | $356K | -21.5% | -29.7% | -13.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.